

<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
    <channel>
        <title>MIMS.com Drug Updates - Singapore</title>
        <description>MIMS.com Drug Updates - Singapore</description>
        <link>www.mims.com</link>
        <language>en</language> 

        
        <item>
            <dc:country>SG</dc:country>
            <title><![CDATA[Twynsta]]></title>
            <description><![CDATA[Indication: Treatment of essential HTN.]]></description>
            <link><![CDATA[http://www.mims.asia/S51061]]></link>
            <author><![CDATA[MIMS.com]]></author>
            <Date>Sat, 12 Mar 2011 00:00:00 GMT</Date>
            
                <category><![CDATA[New Formulations]]></category>
            
        </item>
        
        <item>
            <dc:country>SG</dc:country>
            <title><![CDATA[Inspra]]></title>
            <description><![CDATA[Indication: In addition to standard therapy, to reduce the risk of CV mortality &amp; hospitalization in stable patients w/ left ventricular dysfunction (≤40%) &amp; clinical evidence of heart failure after recent MI.]]></description>
            <link><![CDATA[http://www.mims.asia/S51062]]></link>
            <author><![CDATA[MIMS.com]]></author>
            <Date>Sat, 12 Mar 2011 00:00:00 GMT</Date>
            
                <category><![CDATA[New Molecule]]></category>
            
        </item>
        
        <item>
            <dc:country>SG</dc:country>
            <title><![CDATA[Prolia]]></title>
            <description><![CDATA[Indication: Treatment of postmenopausal women w/ osteoporosis at high risk for fracture.]]></description>
            <link><![CDATA[http://www.mims.asia/S51063]]></link>
            <author><![CDATA[MIMS.com]]></author>
            <Date>Sat, 12 Mar 2011 00:00:00 GMT</Date>
            
                <category><![CDATA[New Molecule]]></category>
            
        </item>
        
    </channel>
</rss>
